文献速递血栓与止血MDS 与骨髓增殖性肿瘤

原发性血小板增多症中的水源性瘙痒与更高血栓风险相关

Aquagenic pruritus in essential thrombocythemia is associated with a higher risk of thrombosis.
PubMed 文献 · J Thromb Haemost · 2019-09-08

基于本机构骨髓增殖性肿瘤患者队列(OBENE数据库,NCT02897297),396例原发性血小板增多症(ET)患者中42例(10.6%)存在水源性瘙痒(AP)。伴AP的ET患者更呈增殖性、诊断时症状更多、治疗更困难,随访期间血栓风险(30.9% vs 17%,P=.03;OR=2.2[1.01;4.66])与疾病表型演进风险(33.3% vs 13.3%,P=.0007;OR=3.2[1.44;6.77])均升高。

要点

  • 396例ET中42例(10.6%)存在水源性瘙痒(AP)。
  • 伴AP者随访血栓发生率30.9% vs 不伴AP者17%(P=.03;OR=2.2[1.01;4.66])。
  • 伴AP者表型演进33.3% vs 13.3%(P=.0007;OR=3.2[1.44;6.77])。

核心结论

  • ET患者中水源性瘙痒(AP)确实存在,并界定出血栓事件与表型演进风险更高的患者群体。
  • 作者认为系统评估ET患者AP有无有助于识别这些高危患者,以改善管理与随访。

研究设计与样本

  • 研究使用本机构骨髓增殖性肿瘤患者队列数据(OBENE数据库,NCT02897297)。
  • 收集诊断时信息、AP有无及随访期间各类并发症;为避免隐匿性PV,所有JAK2阳性病例在适当时检测了同位素红细胞量。

主要发现

  • 396例ET患者中42例(10.6%)存在AP。
  • 伴AP的ET患者更呈增殖性、诊断时症状更多、治疗更困难。
  • 随访期间伴AP者血栓风险升高:30.9% vs 17%(P=.03;OR=2.2[1.01;4.66])。
  • 随访期间伴AP者表型演进风险升高:33.3% vs 13.3%(P=.0007;OR=3.2[1.44;6.77])。

关键数值与推荐

  • ET患者AP患病率为42/396(10.6%)。

临床怎么用

  • 原文建议系统评估ET患者是否存在AP,以更好地识别高血栓及表型演进风险患者并优化管理与随访。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thromboses and phenotypic evolutions (leukemia, myelofibrosis) are the most frequent complications in polycythemia vera (PV) and essential thrombocythemia (ET). Aquagenic pruritus (AP) is not only PV symptom, but is also present in ET. The presence of pruritus in PV is associated with a lower risk of arterial thrombosis. AIMS: To date, no equivalent study has been done to analyse the impact of AP for ET patients. MATERIALS & METHODS: We used the data from our cohort of patients with myeloproliferative neoplasms seen in our institution (OBENE database, NCT02897297). We collect information at diagnosis, presence or not of AP and all types of complications during their follow-up. To avoid masked PV, all JAK2 positive cases were tested isotopic red mass cell if appropriate. RESULTS: Among 396 ET patients, presence of AP was found in 42 (10.6%). ET patients with AP were more proliferative, more symptomatic at diagnosis and more difficult to treat. Furthermore, they presented increased risk of thromboses (30.9 versus 17%, P = .03; OR = 2.2 [1.01;4.66]) and phenotypic evolutions (33.3 versus 13.3%, P = .0007; OR = 3.2 [1.44;6.77]), during follow-up. DISCUSSION: Aquagenic pruritus is classically associated to PV. But we confirmed here that AP is also present in ET and characterizes patients with higher risk of morbidity (thrombotic events and phenotypic evolutions). CONCLUSIONS: The systematic determination of the presence of AP in ET patients should permit us to better identify these high-risk patients for better management and follow-up.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Le Gall-Ianotto C, Le Calloch R, Couturier MA, et al. Aquagenic pruritus in essential thrombocythemia is associated with a higher risk of thrombosis. J Thromb Haemost. 2019. PMID: 31344312. doi:10.1111/jth.14588

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。